Accueil>>Signaling Pathways>> GPCR/G protein>> GPCR19>>INT-777

INT-777 (Synonyms: 6-EMCA, S-EMCA, HY-15677)

Catalog No.GC13681

INT-777 est un nouvel agoniste spécifique semi-synthétique de TGR5 utilisé pour soulager les lésions des cardiomyocytes et améliorer les troubles cognitifs et la dysfonction synaptique dans le modèle de souris atteintes d'Alzheimer.

Products are for research use only. Not for human use. We do not sell to patients.

INT-777 Chemical Structure

Cas No.: 1199796-29-6

Taille Prix Stock Qté
10mM (in 1mL DMSO)
321,00 $US
En stock
2mg
216,00 $US
En stock
5mg
324,00 $US
En stock
10mg
464,00 $US
En stock
50mg
1 391,00 $US
En stock
100mg
1 947,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Protocol Chemical Properties Product Documents Related Products

INT-777 is a novel specific semisynthetic TGR5 agonist used for alleviating cardiomyocyte injury and improving cognitive impairment and synaptic dysfunction in mice model of AD.[1][2]

In vitro, INT-777 induced a dose-dependent (10 μM to 60 μM) decrease in Isc, when INT-777 added on the serosal side of seromuscular stripped distal colon segments in Ussing chambers.[5] In vitro experiment it shown that treatment with 25 μm of INT-777 for 48 h in αTC1-6 cells as well as in mouse and human islets under high glucose conditions obviously increased PC1 mRNA. However, INT-777 (25 μm) had no effect on PC1 mRNA in cells exposed to low glucose conditions.[6] In vitro, combination 100 ng/ml LPS with treatment of 30 μM INT-777 dramatically decreased the transient increase in mRNA levels for Tnfα, monocyte chemoattractant protein-1 (Mcp-1), Il-6 and Il-1β in macrophages.[7]

In vivo efficacy test it indicated that treatment with 30μg/kg of INT-777 dramatically reduced NLRP3-ASC inflammasome activation in microglia, decreased brain edema and neuroinflammation, resulted in improved short-term neurobehavioral functions at 24 h after subarachnoid hemorrhage.[3] In vivo study it suggested that mice were treated with 1.5 or 3.0 μg/mouse INT-777, single intracerebroventricular (i.c.v.) injection of LPS obviously induced mouse behavioral impairments in Morris water maze, novel object recognition, and Y-maze avoidance tests were ameliorated.[7].

References:
[1]. Wu X, et al. Neuroprotective effects of INT-777 against Aβ1-42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice. Brain Behav Immun. 2018 Oct;73:533-545.
[2]. Deng L, et al. Activation of TGR5 Partially Alleviates High Glucose-Induced Cardiomyocyte Injury by Inhibition of Inflammatory Responses and Oxidative Stress. Oxid Med Cell Longev, 2019: 6372786.
[3]. Hu X, et al. INT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5/cAMP/PKA signaling pathway after subarachnoid hemorrhage in rats. Brain Behav Immun. 2021 Jan;91:587-600.
[4]. Wu X, et al. Inhibitory effect of INT-777 on lipopolysaccharide-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:360-374.
[5]. Sorrentino G, et al. Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration. Gastroenterology. 2020 Sep;159(3):956-968.e8.
[6]. Kumar DP, et al. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis. J Biol Chem. 2016 Mar 25;291(13):6626-40.
[7]. Pols TW, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 2011 Dec 7;14(6):747-57.

Avis

Review for INT-777

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for INT-777

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.